Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Henderson

Showing results (51-60 of 161) with videos related to

Pageof 17
Sort By:
Epigenomics|June 5, 2020
Prefrontal cortex eQTLs/mQTLs enriched in genetic variants associated with alcohol use disorder and other diseasesHonghuang Lin, Fan Wang, Andrew J Rosato, et al.
The Journal of Nervous and Mental Disease|August 6, 2005
Building primary care practitioners' attitudes and confidence in mental health skills in a post-conflict society: a Cambodian exampleDavid C Henderson, Richard F Mollica, Svang Tor, et al.
Psychiatry Research|June 26, 2012
Rosiglitazone and cognitive function in clozapine-treated patients with schizophrenia: a pilot studyZhenghui Yi, Xiaoduo Fan, Jijun Wang, et al.
Schizophrenia Research|June 12, 2012
Both physical activity and food intake are associated with metabolic risks in patients with schizophreniaJijun Wang, Xiaoduo Fan, Dengtang Liu, et al.
Transcultural Psychiatry|December 13, 2021
Development of the South Sudan Mental Health Assessment ScaleLauren C Ng, Jordan S Solomon, Maithri Ameresekere, et al.
The Journal of Clinical Psychiatry|May 28, 2004
Clozapine and hypertension: a chart review of 82 patientsDavid C Henderson, Tara B Daley, Laura Kunkel, et al.
Journal of Clinical Psychopharmacology|August 27, 2011
Placebo-controlled pilot study of ramelteon for adiposity and lipids in patients with schizophreniaChristina P C Borba, Xiaoduo Fan, Paul M Copeland, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|August 4, 2005
Modafinil-associated weight loss in a clozapine-treated schizoaffective disorder patientDavid C Henderson, Pearl M Louie, Pamposh Koul, et al.
Psychopharmacology|February 13, 2019
Adjunctive telmisartan treatment on body metabolism in clozapine or olanzapine treated patients with schizophrenia: a randomized, double blind, placebo controlled trialXiaoduo Fan, Paul Copeland, Shukair Nawras, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 1, 2021
Relationship between quality of life and social integration among patients with schizophrenia attending a Nigerian tertiary hospitalTemitope Ogundare, Peter O Onifade, 'Deji Ogundapo, et al.
Pageof 17

Showing results (51-60 of 161) with videos related to

Sort By:
Pageof 17
Epigenomics|June 5, 2020
Prefrontal cortex eQTLs/mQTLs enriched in genetic variants associated with alcohol use disorder and other diseasesHonghuang Lin, Fan Wang, Andrew J Rosato, et al.
The Journal of Nervous and Mental Disease|August 6, 2005
Building primary care practitioners' attitudes and confidence in mental health skills in a post-conflict society: a Cambodian exampleDavid C Henderson, Richard F Mollica, Svang Tor, et al.
Psychiatry Research|June 26, 2012
Rosiglitazone and cognitive function in clozapine-treated patients with schizophrenia: a pilot studyZhenghui Yi, Xiaoduo Fan, Jijun Wang, et al.
Schizophrenia Research|June 12, 2012
Both physical activity and food intake are associated with metabolic risks in patients with schizophreniaJijun Wang, Xiaoduo Fan, Dengtang Liu, et al.
Transcultural Psychiatry|December 13, 2021
Development of the South Sudan Mental Health Assessment ScaleLauren C Ng, Jordan S Solomon, Maithri Ameresekere, et al.
The Journal of Clinical Psychiatry|May 28, 2004
Clozapine and hypertension: a chart review of 82 patientsDavid C Henderson, Tara B Daley, Laura Kunkel, et al.
Journal of Clinical Psychopharmacology|August 27, 2011
Placebo-controlled pilot study of ramelteon for adiposity and lipids in patients with schizophreniaChristina P C Borba, Xiaoduo Fan, Paul M Copeland, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|August 4, 2005
Modafinil-associated weight loss in a clozapine-treated schizoaffective disorder patientDavid C Henderson, Pearl M Louie, Pamposh Koul, et al.
Psychopharmacology|February 13, 2019
Adjunctive telmisartan treatment on body metabolism in clozapine or olanzapine treated patients with schizophrenia: a randomized, double blind, placebo controlled trialXiaoduo Fan, Paul Copeland, Shukair Nawras, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 1, 2021
Relationship between quality of life and social integration among patients with schizophrenia attending a Nigerian tertiary hospitalTemitope Ogundare, Peter O Onifade, 'Deji Ogundapo, et al.
Pageof 17